Litcius/Paper detail

Penpulimab, an anti-PD1 IgG1 antibody in the treatment of advanced or metastatic upper gastrointestinal cancers

Yulong Zheng, Anna Rachelle Mislang, Jermaine Coward, Rasha Cosman, Adam Cooper, Craig Underhill, Jianqing Zhu, Jianping Xiong, Ou Jiang, Hong Wang, Yanru Xie, Yuefen Zhou, Xiaoping Jin, Baiyong Li, Zhongmin Maxwell Wang, Kon Yew Kwek, Dennis Xia, Yu Xia, Nong Xu

2022Cancer Immunology Immunotherapy20 citationsDOIOpen Access PDF

Topics & Concepts

MedicineTolerabilityAdverse effectInternal medicineGastroenterologySorafenibClinical trialCancerOncologyResponse Evaluation Criteria in Solid TumorsPhases of clinical researchHepatocellular carcinomaSurgeryCancer Immunotherapy and BiomarkersHER2/EGFR in Cancer ResearchPancreatic and Hepatic Oncology Research
Penpulimab, an anti-PD1 IgG1 antibody in the treatment of advanced or metastatic upper gastrointestinal cancers | Litcius